Australija - anglų - APVMA (Australian Pesticides and Veterinary Medicines Authority)

nutrien ag solutions limited - metsulfuron-methyl - water dispersible granule - metsulfuron-methyl urea-sulfonyl active 600.0 g/kg - herbicide

Australija - anglų - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - albumin, quantity: 200 g/l - injection, solution - excipient ingredients: sodium; octanoate - hypoproteinaemia in the acutely ill patient albumex 20 is administered when there are existing or anticipated clinical problems or complications from reduced oncotic pressure, and/or as an adjunct to diuretic therapy. shock albumex 20 may be used for the resuscitation of patients in shock due to acute loss of blood or plasma, but 5% human albumin is preferred when available. burns extensive burns are followed by sequential shifts in the distribution of body water, salt and proteins, resulting in hypovolaemic shock and circulatory failure. initially (during the first 24 hours) there is an increased vascular permeability leading to loss of water and proteins into the extravascular compartment, and haemoconcentration. large volumes of crystalloid solutions should be infused to restore the constricted intravascular fluid space, and smaller amounts of albumex 20 are required to maintain adequate plasma volume and colloid osmotic pressure. adult respiratory distress syndrome the clinical syndrome is characterised by inadequate oxygenation secondary to pulmonary interstitial oedema, complicating shock and postoperative states resulting in a decreased central venous pressure, decreased plasma albumin concentration, rising blood pressure, reduced cardiac output, lowered pulse rate and a falling renal output. the acute condition can be controlled by diuretics and albumex 20 in amounts sufficient to maintain vital signs. in patients who have undergone abdominal surgery, the intravenous administration of albumin solution (20%) immediately after the operation has been shown to improve lung compliance and gaseous exchange. haemodialysis albumex 20 may be used to assist with the rapid removal of excess extravascular fluid and to maintain perfusion pressure. therapeutic plasma exchange therapeutic plasma exchange is a procedure in which approximately one plasma volume is exchanged with a colloid replacement solution. the choice of replacement fluid and its concentration are determined by the particular clinical situation and the frequency of the procedure. iso-oncotic albumin solution is the preferred replacement material. if the patient's serum albumin level is not maintained, concentrated albumin (20%) may be indicated. if exchange occurs less frequently than once a week, less concentrated colloids may be appropriate.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - albumin, quantity: 12.5 g - injection, solution - excipient ingredients: sodium; chloride; octanoate - hypovolaemia/shock preservation of an adequate circulating blood volume should be the primary aim of therapy. the initial resuscitating fluid should not be a human blood product, but rather an alternative plasma volume expander should be used as first-line replacement. albumex 5 may, however, be the initial plasma expander of choice if shock is associated with significant hypoalbuminaemia (albumin concentration less than 25 g/litre), or if it is clinically desirable to avoid the infusion of large volumes of crystalloid solutions. albumex 5 may also be useful following initial resuscitation with crystalloid or synthetic colloid solutions in patients in whom extended support of the intravascular volume is required, such as seriously ill patients with multiple organ failure or the systemic capillary leak syndrome. cardiopulmonary bypass albumex 5 may be used for priming the pump for cardiopulmonary bypass surgery for patients with poor left ventricular function, and other complicating factors such as long bypass time, anaemia or repeat surgery. for post-operative hypovolaemia albumex 5 may be used if further colloid is required after a moderate amount of synthetic colloid (1-2l) has been given, or there is ongoing bleeding or anaemia, until cross-matched blood is available. plasma exchange albumex 5 is indicated as a replacement solution in plasma exchange procedures, particularly when the volume exchanged exceeds 20 ml/kg body weight. in patients with thrombotic thrombocytopenic purpura, fresh frozen plasma may be a preferred replacement.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - albumin, quantity: 0.2 g/ml - injection, solution - excipient ingredients: sodium; octanoate - hypoproteinaemia in the acutely ill patient albumex 20 is administered when there are existing or anticipated clinical problems or complications from reduced oncotic pressure, and/or as an adjunct to diuretic therapy. shock: albumex: 20 may be used for the resuscitation of patients in shock due to acute loss of blood or plasma, but 4-5% human albumin is preferred when available. burns: extensive burns are followed by sequential shifts in the distribution of body water, salt and proteins, resulting in hypovolaemic shock and circulatory failure. initially (during the first 24 hours) there is an increased vascular permeability leading to loss of water and proteins into the extravascular compartment, and haemoconcentration. large volumes of crystalloid solutions should be infused to restore the constricted intravascular fluid space, and smaller amounts of albumex 20 are required to maintain adequate plasma volume and colloid osmotic pressure. adult respiratory distress syndrome: the clinical syndrome is characterised by inadequate oxygenation secondary to pulmonary interstitial oedema, complicating shock and postoperative states resulting in a decreased central venous pressure, decreased plasma albumin concentration, rising blood pressure, reduced cardiac output, lowered pulse rate and a falling renal output. the acute condition can be controlled by diuretics and albumex 20 in amounts sufficient to maintain vital signs. in patients who have undergone abdominal surgery, the intravenous administration of albumin solution (20%) immediately after the operation has been shown to improve lung compliance and gaseous exchange. haemodialysis: albumex 20 may be used to assist with the rapid removal of excess extravascular fluid and to maintain perfusion pressure. therapeutic plasma exchange: therapeutic plasma exchange is a procedure in which approximately one plasma volume is exchanged with a colloid replacement solution. the choice of replacement fluid and its concentration are determined by the particular clinical situation and the frequency of the procedure. iso-oncotic albumin solution is the preferred replacement material. if the patient's serum albumin level is not maintained, concentrated albumin (20%) may be indicated. if exchange occurs less frequently than once a week, less concentrated colloids may be appropriate.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - albumin, quantity: 40 g/l - injection - excipient ingredients: sodium; chloride; octanoate - management of hypovolaemia/shock - albumex 4 may be used to help maintain plasma volume. note that other fluids may be needed in the course of treatment. 2.cardiopulmanary bypass- albumex 4 may be used for priming the pump for cardiopulmanary by pass surgery. it may also be used in the treatment of hypovolaemia following cardiopulmonary by pass surgery. 3.albumex 4 may be used in plasma exchange.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - albumin, quantity: 40 g/l - injection, solution - excipient ingredients: octanoate; sodium; chloride - 1. management of hypovolaemia/shock - albumex 4 may be used to help to maintain plasma volume. note that other fluids may be needed in the course of treatment. 2. cardiopulmonary bypass - albumex 4 may be used for priming the pump for cardiopulmonary bypass surgery. it may also be used in the management of hypovolaemia following cardiopulmonary bypass surgery. 3. plasma exchange - albumex 4 may be used in plasma exchange.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - albumin, quantity: 40 g/l - injection, solution - excipient ingredients: sodium; chloride; octanoate - 1. management of hypovolaemia/shock - albumex 4 may be used to help maintain plasma volume. note that other fluids may be needed in the course of treatment. 2. cardiopulmonary bypass - albumex 4 may be used for priming the pump for cardiopulmonary bypass surgery. it may be also be used in the management of hypordaemia following cardiopulmonary bypass surgery. 3. plasma exchange - albumex 4 may be used in plasma exchange.

Australija - anglų - APVMA (Australian Pesticides and Veterinary Medicines Authority)

nutrien ag solutions limited - diflufenican; bromoxynil present as the octanoate - emulsifiable concentrate - diflufenican anilide/aniline-nicotinanilide active 25.0 g/l; bromoxynil present as the octanoate nitrile active 250.0 g/l - herbicide

Australija - anglų - Department of Health (Therapeutic Goods Administration)

integria healthcare australia pty ltd - rumex acetosella, quantity: 26 mg (equivalent: rumex acetosella, qty 130 mg); ulmus rubra, quantity: 32 mg; rheum palmatum, quantity: 1.6 mg (equivalent: rheum palmatum, qty 8 mg; equivalent: hydroxyanthracene derivatives calculated as rhein, qty 140 microgram); arctium lappa, quantity: 48.4 mg (equivalent: arctium lappa, qty 242 mg) - tablet, film coated - excipient ingredients: hypromellose; magnesium stearate; sodium starch glycollate; calcium hydrogen phosphate dihydrate; microcrystalline cellulose - traditionally used in western herbal medicine to alterative/blood cleanser/depurative/purifier ; traditionally used in western herbal medicine to aids/assists body waste elimination ; traditionally used in western herbal medicine to maintain/support body waste elimination ; traditionally used in western herbal medicine to maintain/support general health and wellbeing ; traditionally used in western herbal medicine to decrease/reduce/relieve symptoms of mild eczema/dermatitis ; traditionally used in western herbal medicine to decrease/reduce/relieve symptoms of mild psoriasis ; traditionally used in western herbal medicine to maintain/support skin health

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

ebos group ltd - allergen extracts 10 ic/ml (rumex acetosa pollen extract) - solution for injection - 10 ic/ml - active: allergen extracts 10 ic/ml (rumex acetosa pollen extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water